The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vancomycin     Quarter: 2016Q3

Total Records: 1,050     Number of Pages: 53

DRUGNAME PT EventCount
VANCOMYCIN HYDROCHLORIDE. Venoocclusive liver disease 2
VANCOMYCIN INJECTION, USP Cardiac failure 2
VANCOMYCIN INJECTION, USP Generalised oedema 2
VANCOMYCIN INJECTION, USP Gravitational oedema 2
VANCOMYCIN INJECTION, USP Hypoglycaemia 2
VANCOMYCIN INJECTION, USP Infection 2
VANCOMYCIN INJECTION, USP Intestinal ischaemia 2
VANCOMYCIN INJECTION, USP Lethargy 2
VANCOMYCIN INJECTION, USP Mental status changes 2
VANCOMYCIN INJECTION, USP Peritonitis 2
VANCOMYCIN INJECTION, USP Peritonitis bacterial 2
VANCOMYCIN INJECTION, USP Respiratory distress 2
VANCOMYCIN INJECTION, USP Sepsis 2
VANCOMYCIN INJECTION, USP Septic shock 2
VANCOMYCIN INJECTION, USP Small intestinal obstruction 2
VANCOMYCIN INJECTION, USP Unresponsive to stimuli 2
VANCOMYCIN INJECTION, USP Urine output decreased 2
Vancomycin Mylan Rash maculo-papular 2
VANCOMYCIN SANDOZ Acute kidney injury 2
VANCOMYCIN SANDOZ Drug reaction with eosinophilia and systemic symptoms 2

Total Records: 1,050     Number of Pages: 53